Loading publications…
The last 5 uploaded publications
[<sup>76</sup>Br]BMK‐I‐152, a non‐peptide analogue for PET imaging of corticotropin‐releasing hormone type 1 receptor (CRHR1)
L. Láng, Ying Ma, B. M. Kim, Elaine M. Jagoda, Kenner C. Rice, Lawrence P. Szajek, Carlo Contoreggi, Philip W. Gold, George Chrousos, W.C. Eckelman, Dale O. Kiesewetter (2009). [<sup>76</sup>Br]BMK‐I‐152, a non‐peptide analogue for PET imaging of corticotropin‐releasing hormone type 1 receptor (CRHR1). , 52(9), DOI: https://doi.org/10.1002/jlcr.1616.
Article74 days agoSynthesis of doubly13C-labelled antalarmin isotopomers for pharmacokinetic studies
Elisabeth Greiner, Arthur J. Atkinson, Alejandro Ayala, George Chrousos, Carlo Contoreggi, William C. Eckelman, Philip W. Gold, Kamal E. Habib, Arthur E. Jacobson, Noel F. Whittaker, Elizabeth L. Webster, Kenner C. Rice (2002). Synthesis of doubly13C-labelled antalarmin isotopomers for pharmacokinetic studies. , 45(8), DOI: https://doi.org/10.1002/jlcr.576.
Article74 days agoCRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists
Ling‐Wei Hsin, Xinrong Tian, Elizabeth Webster, Andrew Coop, Timothy M. Caldwell, Arthur E. Jacobson, George Chrousos, Philip W. Gold, Kamal E. Habib, Alejandro Ayala, William C. Eckelman, Carlo Contoreggi, Kenner C. Rice (2002). CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists. , 10(1), DOI: https://doi.org/10.1016/s0968-0896(01)00261-9.
Article74 days agoMarked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs
K. Eddie Gabry, George Chrousos, Kenner C. Rice, R. M. Mostafa, E Sternberg, André Brooking Negrão, Elizabeth Webster, Samuel M. McCann, Philip W. Gold (2002). Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs. , 7(5), DOI: https://doi.org/10.1038/sj.mp.4001031.
Article74 days ago3-O-Formyl-20R,21-epoxyresibufogenin suppresses IL-6–type cytokine actions by targeting the glycoprotein 130 subunit: Potential clinical implications
Tomoshige Kino, Terrence L. Boos, Agnieszka Sulima, Elise M. Siegel, Philip W. Gold, Kenner C. Rice, George Chrousos (2007). 3-O-Formyl-20R,21-epoxyresibufogenin suppresses IL-6–type cytokine actions by targeting the glycoprotein 130 subunit: Potential clinical implications. , 120(2), DOI: https://doi.org/10.1016/j.jaci.2007.03.018.
Article74 days ago